Mobileye’s stock melts down as inventory issues prompt grim revenue warning

The company disclosed that it has “become aware of excess inventory at our customers,” representing an estimated 6 million to 7 million units of the company’s EyeQ product.

Previous post Omega Therapeutics stock more than doubles on Novo Nordisk obesity drug research pact
Next post Bond investors, don’t get fooled: this rebound is just a bear-market rally